• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎(COVID-19)与癌症:全面综述。

COVID-19 and Cancer: a Comprehensive Review.

机构信息

Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Street, Buffalo, NY, 14263, USA.

Department of Medicine, University at Buffalo, Buffalo, NY, USA.

出版信息

Curr Oncol Rep. 2020 May 8;22(5):53. doi: 10.1007/s11912-020-00934-7.

DOI:10.1007/s11912-020-00934-7
PMID:32385672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7206576/
Abstract

PURPOSE OF REVIEW

The outbreak of the novel coronavirus disease 2019 (COVID-19) has emerged to be the biggest global health threat worldwide, which has now infected over 1.7 million people and claimed more than 100,000 lives around the world. Under these unprecedented circumstances, there are no well-established guidelines for cancer patients.

RECENT FINDINGS

The risk for serious disease and death in COVID-19 cases increases with advancing age and presence of comorbid health conditions. Since the emergence of the first case in Wuhan, China, in December 2019, tremendous research efforts have been underway to understand the mechanisms of infectivity and transmissibility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a fatal virus responsible for abysmal survival outcomes. To minimize the mortality rate, it becomes prudent to identify symptoms promptly and employ treatments appropriately. Even though no cure has been established, multiple clinical trials are underway to determine the most optimal strategy. Managing cancer patients under these circumstances is rather challenging, given their vulnerable status and the aggressive nature of their underlying disease. In this comprehensive review, we discuss the impact of COVID-19 on health and the immune system of those affected, reviewing the latest treatment approaches and ongoing clinical trials. Additionally, we discuss challenges faced while treating cancer patients and propose potential approaches to manage this vulnerable population during this pandemic.

摘要

目的综述

新型冠状病毒病 2019(COVID-19)的爆发已成为全球最大的健康威胁,目前已感染全球超过 170 万人,造成超过 10 万人死亡。在这种前所未有的情况下,癌症患者没有既定的治疗指南。

最新发现

COVID-19 病例中严重疾病和死亡的风险随着年龄的增长和合并症的存在而增加。自 2019 年 12 月中国武汉首例病例出现以来,人们一直在进行大量研究,以了解严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)的感染和传播机制,这种致命病毒导致了悲惨的生存结局。为了最大限度地降低死亡率,及时识别症状并进行适当的治疗是明智之举。尽管尚未建立治愈方法,但正在进行多项临床试验以确定最佳策略。在这种情况下,管理癌症患者极具挑战性,因为他们的脆弱状况和潜在疾病的侵袭性。在本次全面综述中,我们讨论了 COVID-19 对受感染者健康和免疫系统的影响,回顾了最新的治疗方法和正在进行的临床试验。此外,我们还讨论了在治疗癌症患者时面临的挑战,并提出了在大流行期间管理这一脆弱人群的潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/e83e39ee2ab5/11912_2020_934_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/5b3762562a1d/11912_2020_934_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/e6d6238d251f/11912_2020_934_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/e83e39ee2ab5/11912_2020_934_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/5b3762562a1d/11912_2020_934_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/e6d6238d251f/11912_2020_934_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1820/7206576/e83e39ee2ab5/11912_2020_934_Fig3_HTML.jpg

相似文献

1
COVID-19 and Cancer: a Comprehensive Review.新型冠状病毒肺炎(COVID-19)与癌症:全面综述。
Curr Oncol Rep. 2020 May 8;22(5):53. doi: 10.1007/s11912-020-00934-7.
2
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
3
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
4
SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.SARS-CoV-2 与 HIV:流行病学、治疗以及从 HIV 中吸取的经验教训。
AIDS Rev. 2020;22(3):133-142. doi: 10.24875/AIDSRev.20000070.
5
The COVID-19 pandemic.新型冠状病毒肺炎(COVID-19)疫情。
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388. doi: 10.1080/10408363.2020.1783198. Epub 2020 Jul 9.
6
Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.2019年新型冠状病毒病(COVID-19)大流行期间成年急性淋巴细胞白血病(ALL)患者的最佳管理
Gulf J Oncolog. 2020 May;1(33):7-18.
7
Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.新型冠状病毒(COVID-19)大流行的临床洞察系统评价:美国农村人口的持续挑战。
Int J Environ Res Public Health. 2020 Jun 15;17(12):4279. doi: 10.3390/ijerph17124279.
8
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.冠状病毒疾病与妊娠:新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征
Przegl Epidemiol. 2020;74(2):276-289. doi: 10.32394/pe.74.21.
9
Responding to Covid-19 - A Once-in-a-Century Pandemic?应对新冠疫情——一场百年一遇的大流行病?
N Engl J Med. 2020 Apr 30;382(18):1677-1679. doi: 10.1056/NEJMp2003762. Epub 2020 Feb 28.
10
Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.全球冠状病毒病 COVID-19/严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫情及相关事件的地理追踪和制图:21 世纪 GIS 技术如何支持全球抗击疫情和传染病。
Int J Health Geogr. 2020 Mar 11;19(1):8. doi: 10.1186/s12942-020-00202-8.

引用本文的文献

1
Safety of immune checkpoint inhibitors in cancer patients with COVID-19: A review.免疫检查点抑制剂在新冠肺炎癌症患者中的安全性:综述
Medicine (Baltimore). 2025 Aug 8;104(32):e43579. doi: 10.1097/MD.0000000000043579.
2
How did states in the United States adapt their cancer control plan in response to the COVID-19 pandemic?美国各州如何根据2019冠状病毒病疫情调整其癌症控制计划?
Public Health Chall. 2024 May 29;3(2):e179. doi: 10.1002/puh2.179. eCollection 2024 Jun.
3
Trends in depression and anxiety prevalence by cancer status among US adults: analyses of the 2019-2022 National Health Interview Survey.

本文引用的文献

1
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.低分子量肝素减轻重症 COVID-19 患者细胞因子风暴的潜力:一项回顾性队列研究。
Clin Transl Sci. 2020 Nov;13(6):1087-1095. doi: 10.1111/cts.12880. Epub 2020 Oct 15.
2
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病(COVID-19)患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
3
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.
美国成年人中按癌症状况划分的抑郁和焦虑患病率趋势:对2019 - 2022年国家健康访谈调查的分析
BMJ Open. 2025 Feb 13;15(2):e090157. doi: 10.1136/bmjopen-2024-090157.
4
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States.2019年冠状病毒病大流行对美国肝细胞癌诊断、分期及治疗的影响
Gastro Hep Adv. 2023 Nov 23;3(2):230-237. doi: 10.1016/j.gastha.2023.11.011. eCollection 2024.
5
Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.COVID-19 大流行期间治疗儿科癌症患者的挑战:平衡风险和护理。
Viruses. 2024 Apr 26;16(5):690. doi: 10.3390/v16050690.
6
Cancer-related fatigue and activities of daily living: lessons learned from the COVID-19 pandemic.癌症相关疲劳与日常生活活动:从新冠疫情中汲取的经验教训
BMC Palliat Care. 2024 Apr 27;23(1):110. doi: 10.1186/s12904-024-01437-z.
7
Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients.病毒表位扫描揭示了季节性 HCoVs 和 SARS-CoV-2 抗体反应在癌症和非癌症患者中的相关性。
Viruses. 2024 Mar 13;16(3):448. doi: 10.3390/v16030448.
8
Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis.COVID-19 疫苗接种前患有癌症的人群因 COVID-19 死亡的风险:系统评价和荟萃分析。
Int J Cancer. 2024 Apr 15;154(8):1394-1412. doi: 10.1002/ijc.34798. Epub 2023 Dec 11.
9
Unexpected changes and associated factors of care burden among caregivers of cancer patients one year after COVID-19 outbreak.新冠疫情爆发一年后癌症患者照料者护理负担的意外变化及相关因素
Heliyon. 2023 Sep 28;9(10):e20504. doi: 10.1016/j.heliyon.2023.e20504. eCollection 2023 Oct.
10
Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19.间充质干细胞治疗 COVID-19 的临床试验。
Curr Stem Cell Res Ther. 2024;19(8):1055-1071. doi: 10.2174/011574888X260032230925052240.
淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
4
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?组织型纤溶酶原激活剂作为难治性新型冠状病毒肺炎相关急性呼吸窘迫综合征的一种新型治疗方法,是否具有作用?
J Trauma Acute Care Surg. 2020 Jun;88(6):713-714. doi: 10.1097/TA.0000000000002694.
5
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
6
COVID-19: immunopathology and its implications for therapy.新型冠状病毒肺炎:免疫病理学及其治疗意义。
Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.
7
Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report.COVID-19 的成功治疗采用体外膜肺氧合,一例报告。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3385-3389. doi: 10.26355/eurrev_202003_20705.
8
Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.中药治疗新型冠状病毒(COVID-19)肺炎:系统评价和荟萃分析的方案。
Syst Rev. 2020 Apr 8;9(1):75. doi: 10.1186/s13643-020-01343-4.
9
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.组织型纤溶酶原激活物(tPA)治疗 COVID-19 相关急性呼吸窘迫综合征(ARDS):病例系列。
J Thromb Haemost. 2020 Jul;18(7):1752-1755. doi: 10.1111/jth.14828. Epub 2020 May 11.
10
Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.静脉注射阿那白滞素治疗巨噬细胞活化综合征可能为治疗2019冠状病毒病细胞因子风暴提供经验教训。
ACR Open Rheumatol. 2020 May;2(5):283-285. doi: 10.1002/acr2.11140. Epub 2020 May 10.